Fate Therapeutics, Inc. (FATE)
1.22
-0.02
(-1.61%)
USD |
NASDAQ |
Apr 02, 16:00
1.215
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics Market Cap : 138.98M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| MannKind Corp. | 753.57M |
| Vertex Pharmaceuticals, Inc. | 109.28B |
| Ardelyx, Inc. | 1.417B |
| ACADIA Pharmaceuticals, Inc. | 3.764B |
| Alnylam Pharmaceuticals, Inc. | 40.99B |
Market Cap Related Metrics
| PS Ratio | 21.37 |
| Price to Book Value | 0.6708 |
| Price | 1.22 |
| Earnings Yield | -96.01% |